PPT-ADNI 3 plans for Biomarker Core

Leslie M Shaw amp John Q Trojanowski Magdalena Korecka Michal Figurski Teresa Waligorska Magdalena Brylska Leona Fields Nirali Shah Biomarker Core Aims for ADNI 3 Continue to collect store curate and track all . Andy Saykin. WW-ADNI Meeting. London, UK. July 14, 2017. asaykin@iupui.edu. Overview and 2017 Updates. ADNI-3 sample collection (banked at NCRAD). Longitudinal DNA & RNA (12 new, 79 continuing). Changes in ADNI-3 include PBMC and RBC collection. AAIC 2017. Presenter: Dr. Patricio . Chrem. . On . Behalf of:. Dr. Prof Ricardo Allegri (PI) . Dr. Gustavo Sevlever. July 14. th. , 2017. Arg. -ADNI. Patients’ Flowchart. Patients Screened at FLENI. Update. Veronika. . Logovinsky. , MD, PhD. . 2017 . Chairperson . WW ADNI Meeting. July . 14, 2017. PPSB: Leadership. Chair. N/A. Chair-elect. Veronika . Logovinsky. , Eisai. FNIH. Michael Biarnes, Scientific Project Manager* . Initiative . December, 2010. NEED FOR VALIDATED BIOMARKERS FOR AD TRIALS. Biomarkers useful in Phase 2 to make decisions about Phase 3 (e.g. doses). Biomarkers useful in Phase 3. Provide additional evidence to support primary outcome findings. Update. James Hendrix. , PhD. 2018 Chairperson . WW ADNI Meeting. July 20, 2018. PPSB: Leadership. Chair. James Hendrix, Alzheimer’s Association . Chair-elect. Aparna . Vasanthakumar. , AbbVie . FNIH. Leslie M Shaw and John Q Trojanowski. WW ADNI meeting. Chicago, July 20, 2018. CSF. Ser. + . Pla. TOTAL. ADNI 1 Primary . Biofluids. Collected. 1118. 9756. 10874. ADNI . 1 Aliquots in Bank. 24934. Boston, MA 4/24/2017 . Leslie M Shaw. John Q Trojanowski. New biomarkers in NIA/ADNI/RARC-approved studies . Biomarker. Fluid. #. ADNI study. Investigator. NFL & Tau . diag. /prognosis. Plasma. 3,000+. Worldwide-ADNI Update Meeting. Friday, July 22, 2016. Fairmont Royal York . Hotel. Toronto. Andy Saykin, . Indiana University. For the Genetics Core/Working Groups. asaykin@iupui.edu. Genetics Core Goals for ADNI-3. John C. Morris, . MD. On behalf of MW Weiner, L Beckett, T . Benzinger. , . D . Coble, . AM Fagan, BA Gordon, P . Massoumzadeh. , L . McCue, . N . Saito, . L Shaw, C . Xiong. , . VD Buckles, . and all Dominantly Inherited Alzheimer Network (DIAN) and Alzheimer Disease Neuroimaging Initiative (ADNI) Investigators. WW-ADNI Meeting, Washington DC. July 17, 2015. Andy Saykin, . Indiana University. asaykin@iupui.edu. For the Genetics Core/Working Groups. Original ADNI-2 Specific Aims. Progress Report & Impact. Silvia Vázquez, Deborah R. . Gustafson. , . Salvador M. Guinjoan, . Ricardo F. Allegri. and . Arg. -ADNI . group. .. Memory and Aging Center. Institute for Neurological Research . (FLENI. ) . Buenos Aires, Argentina. Bret Borowski . Matt Bernstein. Arvin Forghanian-Arani . Jeff Gunter. Dave Jones . Kejal Kantarci. Rob Reid . Denise Reyes . Matt Senjem. Kaely Thostenson. Prashanthi Vemuri . Chad Ward . Funded MRI Investigators. Bret Borowski . Matt Bernstein. Arvin Forghanian-Arani . Jeff Gunter. Dave Jones . Kejal Kantarci. Rob Reid . Denise Reyes . Matt Senjem. Kaely Thostenson. Prashanthi Vemuri . Chad Ward . Funded MRI Investigators. Cliff Jack. Bret Borowski . Matt Bernstein. Arvin Forghanian-Arani . Jeff Gunter. Dave Jones . Kejal Kantarci. Rob Reid . Denise Reyes . Matt Senjem. Kaely Thostenson. Prashanthi Vemuri . Chad Ward .